Jaguar Health, Inc. Share Price

Jaguar Health, Inc. Share Price

NASDAQ: JAGX | Micro Cap
$1.67
-$0.38 (-18.54%) Last updated on 30 Oct, 2026 | 21:41 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Jaguar Health, Inc. Stock Performance

Open
$2.00
Prev. Close
$2.05
Circuit Range
N/A
Day Range
$1.63 - $2.00
Year Range
$0.21 - $41.35
Volume
3,014
Average Traded
$1.77

Jaguar Health, Inc. Share Price Today

As of 30 October 2026, Jaguar Health, Inc.'s share price is $1.67. The stock opened at $2.00, compared to its previous close of $2.05. During today's trading session, Jaguar Health, Inc.'s share price traded between $1.63 and $2.00, with an average price of $1.81. Over the past 52 weeks, the stock has recorded a high of $41.35 and a low of $0.21. In terms of performance, Jaguar Health, Inc.'s share price has declined by 76.01% over the last six months and is down 16.87% on a year-on-year basis.

Jaguar Health, Inc. Share Price Chart

Line chart of the Jaguar Health, Inc. price trend over the selected period. The price fell overall, ranging from 1.63 to 2.00, ending at 1.67.
$1.63$2.00
L
Show Current Price
H

Jaguar Health, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.90M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-22.56
Revenue (TTM)
$11.51B
Return On Equity (TTM)
-792.44%
Profit Margin
-465.51%
Debt to Equity
2.35
Quarterly Earnings Growth YoY
-33.68%

Jaguar Health, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3.08$3.24$20.27$1.23
Net Profit-$9.50-$23.20-$7.02-$12.70
Net Profit Margin-308.44%-716.05%-34.63%-1032.52%
Income ChangeN/A-144.21%69.74%-80.91%

Jaguar Health, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$11.96$9.76$11.69$11.51
Net Profit-$47.45-$41.30-$38.49-$53.58
Net Profit Margin-396.74%-423.16%-329.26%-465.51%
Income ChangeN/A12.96%6.80%-39.20%

About Jaguar Health, Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Jaguar Health, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$4.26
$1.66
-63.47%
Sep 2026
$0.73
$4.53
+418.90%
Aug 2026
$0.98
$0.87
-13.56%
Jul 2026
$2.99
$1.01
-65.88%
Jun 2026
$3.12
$2.96
-6.33%
May 2026
$7.61
$3.16
-54.60%
Apr 2026
$0.44
$6.96
+1,801.64%
Mar 2026
$0.89
$0.37
-58.74%
Feb 2026
$0.67
$0.89
+30.25%
Jan 2026
$0.93
$0.68
-26.54%
Dec 2025
$1.21
$0.93
-30.30%
Nov 2025
$2.00
$1.33
-33.80%

JAGX Share Price FAQs